BioMarin and Cardinal Health Receive 'Outperform' Ratings from Analysts

BioMarin was initiated with an 'outperform' rating by BMO, with analysts suggesting that concerns about Voxzogo erosion are overstated. Cardinal Health also received a new 'outperform' rating from RBC, citing higher margin services.